Excellence Future International Consulting Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Excellence Future International Consulting Co., Ltd. - overview
Established
2002
Location
Beijing, -, China
Primary Industry
Pharmaceuticals
About
Founded in 2002 and headquartered in Beijing, China, Excellence Future International Consulting Co. , Ltd. was established by a group of professionals committed to advancing China’s clinical research and new drug development. Over the past two decades, the company has expanded from a clinical CRO into a comprehensive service provider covering SMO and preclinical research.
As of 2024, the firm employs over 1,600 professionals and collaborates with more than 1,000 research centers across 30 provinces and municipalities in China. The company has executed over a thousand clinical research projects across fields such as oncology, neurology, cardiology, pediatrics, orthopedics, and anesthesiology, establishing itself as one of China’s leading CRO enterprises. In September 2022, it closed a round of venture funding. Excellence Future International Consulting Co.
, Ltd. provides a full range of clinical research and pharmaceutical development services, including clinical trial design and execution, site management (SMO), data management and statistical analysis, medical writing, drug safety monitoring, registration consulting and subject recruitment. The company generates revenue through service contracts with domestic and international pharmaceutical and biotechnology firms, research institutes and medical device companies.
Current Investors
Galaxy Capital Management, Galaxy Luckystar VC, Beijing E-town international Industrial Investment Management
Primary Industry
Pharmaceuticals
Sub Industries
Intellectual Property, Biopharmaceuticals, Alternative Medicine, Medical Equipment Distributors, Pharmaceutical Research & Development
Website
www.chncro.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.